Trials / Conditions / Malignant Neoplasms of Male Genital Organs
Malignant Neoplasms of Male Genital Organs
7 registered clinical trials studyying Malignant Neoplasms of Male Genital Organs.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT NCT03435952 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Neuromuscular Blockade on Shoulder Pain of Elderly NCT03210376 | M.D. Anderson Cancer Center | Phase 4 |
| Active Not Recruiting | Selumetinib and Olaparib in Solid Tumors NCT03162627 | M.D. Anderson Cancer Center | Phase 1 |
| Withdrawn | Neoadjuvant Listeria or Daratumumab in Prostate Cancer NCT03035357 | M.D. Anderson Cancer Center | Phase 2 |
| Withdrawn | Lenvatinib and Capecitabine in Patients With Advanced Malignancies NCT02915172 | M.D. Anderson Cancer Center | Phase 1 |
| Withdrawn | Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies NCT02812056 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis NCT02740127 | M.D. Anderson Cancer Center | Phase 3 |